Hepatitis B Explainer
Hepatitis B is a liver infection caused by the hepatitis B virus, often abbreviated HBV. The infection can be acute, meaning relatively short-term, or chronic, meaning it persists over time. Many people have few or no symptoms, so feeling well does not reliably show whether the virus is present. Chronic infection can damage the liver and increase the risk of cirrhosis and liver cancer. Testing, prevention, and appropriate ongoing care are therefore important even when an infection is not immediately noticeable.
HBV spreads when infected blood or certain other body fluids enter another person’s body. Transmission can occur during birth, through sexual contact, or through exposure involving shared needles or contaminated equipment. It does not spread through ordinary activities such as hugging, coughing, or sharing food and utensils. This distinction matters both for prevention and for avoiding unnecessary stigma. A person’s diagnosis is a reason to understand the actual routes of transmission, rather than to exclude them from everyday social contact.
Blood testing can identify evidence of current infection, past exposure, or immunity. These are different questions, and a single marker does not always answer all of them. Screening commonly uses a combination of tests for a viral antigen and antibodies. A clinician interprets the pattern and decides whether additional assessment is needed. A positive result should come with an explanation of what was measured and what it means, instead of leaving the patient to interpret an unfamiliar abbreviation alone.
Vaccination can prevent hepatitis B, but it does not treat an infection that is already established. Care for chronic infection may involve antiviral medicines and regular monitoring, depending on the person’s circumstances. Treatment can suppress the virus and reduce the risk of liver complications without necessarily eliminating it completely. Decisions consider viral activity, liver health, and other factors. The practical aim is to connect prevention, testing, and follow-up so that infection is identified and managed appropriately.
The chance that an infection becomes chronic is strongly influenced by the age at which it occurs. Infection acquired early in life is more likely to persist than infection acquired in adulthood. This helps explain why prevention around birth and during childhood is important. It also means that someone's current age or apparent health cannot reveal when an infection began or whether it has persisted.
When symptoms occur, they can include fatigue, nausea, abdominal discomfort, dark urine, and jaundice, the yellowing of skin or eyes. These symptoms are not unique to hepatitis B. An examination and appropriate tests are needed to establish the cause. Because infection can also remain silent, waiting for a recognizable symptom pattern is not an adequate substitute for screening when screening is indicated.
The surface antigen is a marker associated with current infection. Antibodies to the surface antigen can indicate immunity, while antibodies to the core antigen provide information about exposure to the virus. Vaccination and past infection can therefore produce different patterns. The combination matters: it allows a clinician to distinguish situations that would be unclear if only one result were considered.
Testing after a possible exposure and routine screening do not always follow the same timetable or answer the same immediate question. The timing of infection can affect which markers are detectable. Additional tests may assess the amount of virus or the condition of the liver. A clear follow-up plan explains whether a result needs confirmation, further investigation, or monitoring over time.
Vaccination recommendations depend on age, medical history, prior vaccination, and the applicable public-health guidance. People can confirm what protection they already have and which plan applies to them. Preventing exposure to blood and using appropriately sterilized equipment also remain relevant. These measures address actual routes of transmission and work alongside vaccination, rather than relying on assumptions about someone's appearance or background.
Monitoring chronic hepatitis B looks at both the infection and the liver's response. A person who feels well may still need regular review, while a changing test result can require a reassessment of treatment. Some people also need surveillance for liver cancer according to their risk. Knowing who is responsible for follow-up and when the next review is due helps turn a diagnosis into a sustained plan of care.
Explore more "Explainers"
Discover additional explainers across politics, science, business, technology, and other fields. Each explainer breaks down a complex idea into clear, everyday language—helping you better understand how major concepts, systems, and debates shape the world around us.